This HTML5 document contains 59 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n8http://localhost/temp/predkladatel/
n12http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n6http://linked.opendata.cz/resource/domain/vavai/subjekt/
n5http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n18http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n16http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61989592%3A15110%2F13%3A33145914%21RIV14-MSM-15110___/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61989592%3A15110%2F13%3A33145914%21RIV14-MSM-15110___
rdf:type
n5:Vysledek skos:Concept
dcterms:description
Aim of this trial was to assess (1) the accuracy and precision of elektrochemistry-based glucometers CONTOURLINK, CALLA, and LINUS and (2) the diabetes control using Ambulatory Glycaemic Profiles (AGP) as markers of therapeutic effectiveness. Glucometers and COBAS INTEGRA 400 Plus analyzer were used by one laboratory professional to estimate P-glucose (PG) in 112 out-patients. There were 112 sets of 12 PG estimations analyzed. In each set, means of 3 capillary PG estimations on 3 respective glucometers and on INTEGRA analyzer were calculated. The statistical program SPSS, v. 15, was applied. The mean INTEGRA PG values ranged from 2.7 to 25.3 mmol/l. There were strong correlations between mean PG on INTEGRA versus CONTOURLINK, versus CALLA, and versus LINUS; PG deviations from INTEGRA were mostly within the range +-15%. Wilcoxon Signed Rank Test revealed differences between CONTOURLINK-INTEGRA and LINUS-INTEGRA; CALLA-INTEGRA showed no difference SD INTEGRA = 0.061 mmol/l, SD CONTOURLINK/SD CALLA/SD LINUS were 0.256/0.290/0.286 mmol/l. All patients were trained to perform defined 10-point PG profiles to adapt food, exercise, and insulin doses. The PG differences between all tested glucometers and reference values were borderline of ISO 15197 but worthy of consideration. AGP are felpful markers of diabetes control. Aim of this trial was to assess (1) the accuracy and precision of elektrochemistry-based glucometers CONTOURLINK, CALLA, and LINUS and (2) the diabetes control using Ambulatory Glycaemic Profiles (AGP) as markers of therapeutic effectiveness. Glucometers and COBAS INTEGRA 400 Plus analyzer were used by one laboratory professional to estimate P-glucose (PG) in 112 out-patients. There were 112 sets of 12 PG estimations analyzed. In each set, means of 3 capillary PG estimations on 3 respective glucometers and on INTEGRA analyzer were calculated. The statistical program SPSS, v. 15, was applied. The mean INTEGRA PG values ranged from 2.7 to 25.3 mmol/l. There were strong correlations between mean PG on INTEGRA versus CONTOURLINK, versus CALLA, and versus LINUS; PG deviations from INTEGRA were mostly within the range +-15%. Wilcoxon Signed Rank Test revealed differences between CONTOURLINK-INTEGRA and LINUS-INTEGRA; CALLA-INTEGRA showed no difference SD INTEGRA = 0.061 mmol/l, SD CONTOURLINK/SD CALLA/SD LINUS were 0.256/0.290/0.286 mmol/l. All patients were trained to perform defined 10-point PG profiles to adapt food, exercise, and insulin doses. The PG differences between all tested glucometers and reference values were borderline of ISO 15197 but worthy of consideration. AGP are felpful markers of diabetes control.
dcterms:title
Effective Assessment of Diabetes Control Using Personal Glucometers (Contourlink, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA) Effective Assessment of Diabetes Control Using Personal Glucometers (Contourlink, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA)
skos:prefLabel
Effective Assessment of Diabetes Control Using Personal Glucometers (Contourlink, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA) Effective Assessment of Diabetes Control Using Personal Glucometers (Contourlink, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA)
skos:notation
RIV/61989592:15110/13:33145914!RIV14-MSM-15110___
n5:predkladatel
n6:orjk%3A15110
n3:aktivita
n18:I
n3:aktivity
I
n3:cisloPeriodika
6
n3:dodaniDat
n9:2014
n3:domaciTvurceVysledku
n12:7572085 n12:2983486 n12:7247621 n12:8525455 n12:3719979
n3:druhVysledku
n17:J
n3:duvernostUdaju
n15:S
n3:entitaPredkladatele
n16:predkladatel
n3:idSjednocenehoVysledku
71851
n3:idVysledku
RIV/61989592:15110/13:33145914
n3:jazykVysledku
n7:eng
n3:klicovaSlova
USA; Agamatrix; LINUS; Austria; Wellion; CALLA; Germany; Bayer; Contourlink; Glucometers; Personal; Using; Control; Diabetes; Assessment; Effective
n3:klicoveSlovo
n4:Diabetes n4:Contourlink n4:Assessment n4:USA n4:Glucometers n4:Austria n4:Agamatrix n4:CALLA n4:Wellion n4:Bayer n4:Using n4:LINUS n4:Control n4:Germany n4:Effective n4:Personal
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[872831B28DB1]
n3:nazevZdroje
Disease Markers
n3:obor
n14:FB
n3:pocetDomacichTvurcuVysledku
5
n3:pocetTvurcuVysledku
6
n3:rokUplatneniVysledku
n9:2013
n3:svazekPeriodika
35
n3:tvurceVysledku
Procházka, Vlastimil Doubravová, B. Krystyník, Ondřej Zapletalová, Jana Chlup, Rudolf Bartek, Josef
s:issn
1875-8630
s:numberOfPages
11
n8:organizacniJednotka
15110